Skip to main content

Table 1 Sociodemographic and other characteristics of the patients (N = 206)a

From: Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS)

  Frequency (%)
Gender Men 89 (43.2%)
Women 117 (56.8%)
Marital status Single 168 (82%)
Married 28 (13.7%)
Divorced 9 (4.3%)
Educational level Primary 128 (63.4%)
Secondary 57 (28.2%)
University 17 (8.4%)
Intake of psychoactive substances No 196 (95.1%)
Yes 10 (4.9%)
Alcohol intake No 189 (92.2%)
Yes 16 (7.8%)
Smoking No 90 (43.9%)
Yes 115 (56.1%)
Presence of family history of schizophrenic episodes No 162 (78.6%)
Yes 44 (21.4%)
Presence of family history of other psychiatric diseases No 185 (89.9%)
Yes 21 (10.2%)
  Mean ± Standard Deviation
Age (in years) 52.68 ± 12.00
Chlorpromazine total equivalent dose (in mg) 1150.91 ± 973.70
Chlorpromazine equivalent dose for typical antipsychotics (in mg) 1010.57 ± 973.63
Chlorpromazine equivalent dose for atypical antipsychotics (in mg) 163.57 ± 305.97
  1. a Some variables did not sum up to 206 due to missing data